MedPath

Michael Scharl

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

Not Applicable
Completed
Conditions
Fecal Microbiota Transplantation
Cancer
Immunotherapy
Immune Checkpoint Inhibitors
Interventions
Biological: Fecal Microbiota Transplantation (FMT)
First Posted Date
2022-03-10
Last Posted Date
2025-03-28
Lead Sponsor
Michael Scharl
Target Recruit Count
18
Registration Number
NCT05273255
Locations
🇨🇭

University of Zurich, University Hospital Zurich, Zurich, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.